Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) shared three-year results from its pivotal ORBIT II study in a featured clinical research ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

Leerink Partners Raises Price Target as Cardiovascular Systems (CSII) Reports Above Preannouncement May 5, 2016 8:52 AM Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual MeetingMay 5, 2016 8:04 AM Cardiovascular Systems (CSII) Misses Q3 EPS by 15cMay 4, 2016 5:36 PM Form 8-K Cardiovascular Systems For: May 04May 4, 2016 4:16 PM Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial ResultsMay 4, 2016 4:06 PM